Certified by Founder
Lodge
Psylo
start up
Australia
- Sydney, NSW
- 04/06/2024
- Seed
- $8,000,000
Psylo is a drug development company focused on next generation psychedelics; our goal is to make broadly accessible medicines as improved treatments to currently available SSRI medications, using psychedelic molecules as the starting point. We are building a pipeline of novel molecules with the ultimate goal of taking leading candidates through to clinical trials.
- Industry Biotechnology
- Website https://psylo.bio/
- LinkedIn https://www.linkedin.com/company/psylo/
NuCube Energy | $13,000,000 | (Feb 20, 2026)
Vizzia | $35,300,400 | (Feb 20, 2026)
PolyGone Systems Inc | $4,000,000 | (Feb 20, 2026)
Altesa BioSciences, Inc. | $75,000,000 | (Feb 20, 2026)
Eagle Wireless | $30,000,000 | (Feb 20, 2026)
Stacks | $23,000,000 | (Feb 20, 2026)
SPRX | $31,000,000 | (Feb 20, 2026)
Adronite | $5,000,000 | (Feb 20, 2026)
Odynn | $9,500,000 | (Feb 20, 2026)
Ascent(US) | $45,000,000 | (Feb 20, 2026)
Ownwell | $50,000,000 | (Feb 20, 2026)
Badge | $17,100,000 | (Feb 20, 2026)